| P50 | author | Eleni A Greenwood | Q41138390 |
| | Marcelle I Cedars | Q107649328 |
| P2093 | author name string | Richard S Legro | |
| | Esther Eisenberg | |
| | Heather G Huddleston | |
| | Lauri A Pasch | |
| | Eunice Kennedy Shriver National Institute of Child Health and Human Development Reproductive Medicine Network | |
| P2860 | cites work | Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 |
| | The prevalence of comorbid depression in adults with diabetes: a meta-analysis | Q28190708 |
| | Use and abuse of HOMA modeling | Q28263292 |
| | The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial | Q28394688 |
| | Letrozole versus clomiphene for infertility in the polycystic ovary syndrome | Q30408628 |
| | Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism | Q30429467 |
| | Should Depressive Syndromes Be Reclassified as "Metabolic Syndrome Type II"? | Q31138845 |
| | Insulin resistance and depression: cross sectional study | Q33584178 |
| | Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire | Q33777234 |
| | Depression and insulin resistance: cross-sectional associations in young adults | Q33804724 |
| | Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease | Q33940256 |
| | Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis | Q34099068 |
| | Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). | Q34285382 |
| | The relationship between clinicobiochemical markers and depression in women with polycystic ovary syndrome | Q35089757 |
| | Depression, distress and self-efficacy: The impact on diabetes self-care practices | Q36330248 |
| | Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease | Q36624198 |
| | Downregulation of hypothalamic insulin receptor expression elicits depressive-like behaviors in rats | Q37174023 |
| | Functional neuroimaging of emotional processing in women with polycystic ovary syndrome: a case-control pilot study | Q37509051 |
| | Sugar for the brain: the role of glucose in physiological and pathological brain function | Q37511476 |
| | Dietary restriction reverses obesity-induced anhedonia | Q37719351 |
| | Metabolic syndrome and major depression | Q38150605 |
| | Hirsutism: implications, etiology, and management | Q38481934 |
| | Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies | Q39026021 |
| | High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis | Q39195587 |
| | Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls | Q40505331 |
| | Putative role for insulin resistance in depression risk in polycystic ovary syndrome. | Q40858171 |
| | Weight Loss and Lowering Androgens Predict Improvements in Health-Related Quality of Life in Women With PCOS. | Q42384443 |
| | Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome | Q42692453 |
| | Associations between depressive symptoms and insulin resistance: the Hoorn Study | Q43823415 |
| | Depression in women with polycystic ovary syndrome: clinical and biochemical correlates | Q44434688 |
| | The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria | Q45081416 |
| | The relationship between clinico-biochemical characteristics and psychiatric distress in young women with polycystic ovary syndrome | Q46191484 |
| | Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus | Q48287240 |
| | Biological correlates of major depression and generalized anxiety disorder in women with polycystic ovary syndrome | Q48510865 |
| | Insulin receptors are widely distributed in human brain and bind human and porcine insulin with equal affinity | Q48546028 |
| | Increased risk of depressive disorders in women with polycystic ovary syndrome. | Q50801730 |
| | Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study. | Q51405718 |
| | Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. | Q51552638 |
| | Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. | Q51555713 |
| | Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. | Q51944915 |
| | Insulin resistance-a missing link no more. | Q53767591 |
| | Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS) | Q84863945 |
| | Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome | Q85067344 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | reproductive medicine | Q351870 |
| | polycystic ovary syndrome | Q500816 |
| | polycystic ovary | Q5547896 |
| | insulin resistance | Q1053470 |
| | gynaecology | Q1221899 |
| | obstetrics | Q5284418 |
| P304 | page(s) | 27-34 | |
| P577 | publication date | 2018-06-13 | |
| P1433 | published in | Fertility and Sterility | Q15724525 |
| P1476 | title | Insulin resistance is associated with depression risk in polycystic ovary syndrome | |
| P478 | volume | 110 | |